Latvia - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Latvia Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases increased 35.4% year on year. In 2019, the country was number 86 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases at 323 Cases. Latvia is overtaken by Zimbabwe, which was ranked number 85 at 331 Cases and is followed by Georgia at 319 Cases. India ranked the highest with 66,255 Cases in 2019, +13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia was the worst growing country at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 323.00 |
| 2018 | |
| 2017 | 48.00 |
| 2016 | 56.00 |
| 2015 | 63.00 |
How does Latvia rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 84 |
#84
Lesotho
|
340 | 2019 | +4.6 % | +18.1 % | View data | |
| 86 |
#86
Latvia
|
323 | 2019 | NA | +35.4 % | View data | |
| 88 |
#88
Ecuador
|
317 | 2019 | +25.8 % | -6.8 % | View data | |